1821: DIAGNOSTIC CHALLENGES AND TREATMENT OF MALIGNANT CATATONIA WITH ELECTROCONVULSIVE THERAPY

2016 ◽  
Vol 44 (12) ◽  
pp. 530-530
Author(s):  
Claudia Onofrei ◽  
Ranjeet Singh ◽  
Catherine Sears
2009 ◽  
Vol 15 (3) ◽  
pp. 181-191 ◽  
Author(s):  
Niraj Ahuja ◽  
Andrew J. Cole

SummaryPresence of fever in psychiatric patients may signify a number of potentially fatal conditions. Several of these are related to treatments (e.g. neuroleptic malignant syndrome with antipsychotics, serotonin syndrome with serotonergic antidepressants, and malignant hyperpyrexia with anaesthesia used for administration of electroconvulsive therapy) or exacerbated by them (e.g. malignant catatonia with antipsychotics). New classes of drug treatment may be changing the epidemiology of these disorders. We suggest that an initial diagnosis of hyperthermia syndrome is clinically useful as there are some important commonalities in treatment. We outline a systematic approach to identify a particular subtype of hyperthermia syndrome and the indications for more specific treatments where available.


2015 ◽  
Vol 132 (4) ◽  
pp. 319-320 ◽  
Author(s):  
L. Wachtel ◽  
E. Commins ◽  
M. Park ◽  
N. Rolider ◽  
R. Stephens ◽  
...  

2006 ◽  
Vol 84 (1) ◽  
pp. 178-179 ◽  
Author(s):  
Rainer Marco Kaufmann ◽  
Daniel Schreinzer ◽  
Alexandra Strnad ◽  
Nilufar Mossaheb ◽  
Siegfried Kasper ◽  
...  

2009 ◽  
Vol 102 (11) ◽  
pp. 1170-1172 ◽  
Author(s):  
Dirk M. Dhossche ◽  
Shashidhar M. Shettar ◽  
Tarun Kumar ◽  
Laura Burt

2013 ◽  
Vol 2013 ◽  
pp. 1-5
Author(s):  
Sophia Wong ◽  
Barbara Hughes ◽  
Morris Pudek ◽  
Dailin Li

Malignant catatonia is an unusual and highly fatal neuropsychiatric condition which can present with clinical and biochemical manifestations similar to those of pheochromocytoma. Differentiating between the two diseases is essential as management options greatly diverge. We describe a case of malignant catatonia in a 20-year-old male who presented with concurrent psychotic symptoms and autonomic instability, with markedly increased 24-hour urinary levels of norepinephrine at 1752 nmol/day (normal, 89–470 nmol/day), epinephrine at 1045 nmol/day (normal, <160 nmol/day), and dopamine at 7.9 μmol/day (normal, 0.4–3.3 μmol/day). The patient was treated with multiple sessions of electroconvulsive therapy, which led to complete clinical resolution. Repeat urine collections within weeks of this presenting event revealed normalization or near normalization of his catecholamine and metanephrine levels. Malignant catatonia should be considered in the differential diagnosis of the hypercatecholamine state, particularly in a patient who also exhibits concurrent catatonic features.


Sign in / Sign up

Export Citation Format

Share Document